SoftOx Solutions AS Logo

SoftOx Solutions AS

Develops non-toxic, AMR-safe antimicrobials for wound care, disinfection & airway infections.

SOFTX | OL

Overview

Corporate Details

ISIN(s):
NO0010811961 (+2 more)
LEI:
549300AETMWJS91G4A50
Country:
Norway
Address:
Martin Linges vei 25, 1364 Fornebu
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SoftOx Solutions AS is a clinical-stage pharmaceutical company developing a patented, non-toxic antimicrobial technology to address significant global health threats. The company's platform stabilizes a naturally occurring molecule (hypochlorous acid) to create highly effective solutions against a broad spectrum of pathogens, including bacteria, viruses, fungi, and biofilms. A key advantage of this technology is its mechanism of action, which does not contribute to the development of antimicrobial resistance (AMR). The company's primary focus includes an inhalation solution for airway infections, as well as products for advanced wound care and disinfection. SoftOx develops its technology in collaboration with leading scientific and clinical research institutions.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SoftOx Solutions AS and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-17 08:00
Interim Report
SoftOx Solutions AS: Second Quarter/Half-Year Report 2025 - Attachment: SoftOx …
English 1.1 MB
2025-09-17 08:00
Report Publication Announcement
SoftOx Solutions AS: Second Quarter/Half-Year Report 2025
English 367 bytes
2025-09-11 15:59
Capital/Financing Update
SoftOx Solutions AS: Softox Solutions AS exercises on the financing facility wi…
English 1.9 KB
2025-09-08 12:07
Investor Presentation
SoftOx Solutions AS: Presentation Deck and link to today's Investor Update - At…
English 3.7 MB
2025-09-08 12:07
Investor Presentation
SoftOx Solutions AS: Presentation Deck and link to today's Investor Update
English 619 bytes
2025-09-08 08:00
Regulatory News Service
SoftOx Solutions AS: Reminder - Investor Update in connection with the Refinem…
English 1.6 MB
2025-09-08 08:00
Report Publication Announcement
SoftOx Solutions AS: Reminder - Investor Update in connection with the Refinem…
English 937 bytes
2025-09-03 12:39
Regulatory News Service
SoftOx Solutions AS: Investor Update in connection with the Refinement of the C…
English 1.6 MB
2025-09-03 12:39
Report Publication Announcement
SoftOx Solutions AS: Investor Update in connection with the Refinement of the C…
English 915 bytes
2025-09-02 08:59
ISS
SoftOx Solutions AS: Refines Clinical Focus and Advances Into Chronic Lung Dise…
Norwegian 8.7 KB
2025-08-26 14:35
Director's Dealing
SoftOx Solutions AS: Primary Insider Notification - Attachment: Skjema for meld…
Norwegian 125.5 KB
2025-08-26 14:35
Related Party Transaction
SoftOx Solutions AS: Primary Insider Notification - Attachment: Skjema for meld…
Norwegian 131.5 KB
2025-08-26 14:35
Director's Dealing
SoftOx Solutions AS: Primary Insider Notification - Attachment: Skjema for meld…
Norwegian 125.5 KB
2025-08-26 14:35
Director's Dealing
SoftOx Solutions AS: Primary Insider Notification
English 2.1 KB
2025-08-18 10:36
Share Issue/Capital Change
SoftOx Solutions AS: New Share Capital
English 1.6 KB

Automate Your Workflow. Get a real-time feed of all SoftOx Solutions AS filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SoftOx Solutions AS via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK

Talk to a Data Expert

Have a question? We'll get back to you promptly.